Suppr超能文献

新型冠状病毒肺炎管理的现状与未来展望

Current Scenario and Future Prospect in the Management of COVID-19.

作者信息

Borah Pobitra, Deb Pran Kishore, Deka Satyendra, Venugopala Katharigatta N, Singh Vinayak, Mailavaram Raghu Prasad, Kalia Kiran, Tekade Rakesh Kumar

机构信息

Pratiksha Institute of Pharmaceutical Sciences, Chandrapur Road, Panikhaiti, Guwahati-781026, Assam, India.

Department of Pharmaceutical Sciences, Faculty of Pharmacy, Philadelphia University, PO Box 1, Amman 19392, Jordan.

出版信息

Curr Med Chem. 2021;28(2):284-307. doi: 10.2174/0929867327666200908113642.

Abstract

The COVID-19 pandemic continues to wreak havoc worldwide due to the lack of risk assessment, rapid spreading ability, and propensity to precipitate severe disease in comorbid conditions. In an attempt to fulfill the demand for prophylactic and treatment measures to intercept the ongoing outbreak, the drug development process is facing several obstacles and renaissance in clinical trials, including vaccines, antivirals, immunomodulators, plasma therapy, and traditional medicines. This review outlines the overview of SARS-CoV-2 infection, significant recent findings, and ongoing clinical trials concerning current and future therapeutic interventions for the management of advancing pandemic of the century.

摘要

由于缺乏风险评估、快速传播能力以及在合并症中引发严重疾病的倾向,新冠疫情仍在全球肆虐。为了满足拦截当前疫情的预防和治疗措施需求,药物研发过程在临床试验中面临诸多障碍并迎来复兴,这些措施包括疫苗、抗病毒药物、免疫调节剂、血浆疗法和传统药物。本综述概述了新型冠状病毒感染的概况、近期的重要发现以及当前正在进行的关于管理本世纪不断蔓延的大流行的治疗干预措施的临床试验情况。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验